[144] uniQure N.V. SEC Filing

Rhea-AI Filing Summary

uniQure N.V. (QURE) reported a Form 144 notification showing the proposed sale of 226,316 ordinary shares by a person associated with the company. The shares are to be sold through Citigroup Global Markets on 09/24/2025 with an aggregate market value of $9,381,750.00. The filing states these shares were acquired on 09/24/2025 via stock option exercise and sale pursuant to a Rule 10b5-1 plan, and payment was made in cash. The issuer has 54,866,930 shares outstanding, so the shares notified represent approximately 0.41% of outstanding stock. The filer indicates no other sales in the prior three months and includes the standard certification that no undisclosed material information is known.

Positive

• Sale executed under a Rule 10b5-1 plan, which indicates preplanned and compliant trading
• Relatively small share proportion sold (~0.41% of outstanding shares), limiting market impact

Negative

• Insider sale valued at $9.38M could be perceived negatively by some investors despite being preplanned
• No plan adoption date disclosed in this notice, so readers cannot confirm timing relative to material events

Insights

Securities Analyst

TL;DR: Insider sold ~0.41% of outstanding shares via an option exercise under a 10b5-1 plan; transaction appears routine and compliance-focused.

The Form 144 documents a sale of 226,316 ordinary shares valued at $9.38M executed through Citigroup on 09/24/2025, originating from a stock option exercise and sale under a Rule 10b5-1 plan. Relative to the issuer's 54.87M shares outstanding, the position is modest (~0.41%). Because the filing cites a 10b5-1 execution and shows no other sales in the prior three months, this looks like an orderly, preplanned disposition rather than an opportunistic insider sale. For market impact, the size is unlikely to be material to valuation or float, though it increases near-term selling supply.

Corporate Governance Expert

TL;DR: Transaction follows standard governance safeguards; disclosure is consistent with Rule 144 and 10b5-1 documentation.

The notice states the sale arises from an option exercise and was executed pursuant to a Rule 10b5-1 plan, which, if properly adopted, provides an affirmative defense against insider trading allegations for preplanned trades. The filer also affirms no undisclosed material information. Absent additional context on the plan adoption date or insider role, governance implications are limited to routine insider liquidity and do not by themselves signal management concerns. Review of the underlying 10b5-1 adoption date and any contemporaneous disclosures would clarify governance timing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013	226316	9381750.00	54866930	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	09/24/2025	STOCK OPTION EXERCISE AND SALE PURSUANT TO 10B51 PLAN	UNIQURE NV			226316	09/24/2025	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by uniQure (QURE) disclose?

The Form 144 notifies a proposed sale of 226,316 ordinary shares through Citigroup on 09/24/2025, with an aggregate market value of $9,381,750.00.

Why were the uniQure shares being sold?

The filing states the shares were acquired and sold via a stock option exercise and sale pursuant to a Rule 10b5-1 plan, with payment in cash.

How large is the sale relative to uniQure's outstanding shares?

The issuer reports 54,866,930 shares outstanding; the 226,316-share notice represents about 0.41% of outstanding stock.

Does the Form 144 show other recent insider sales?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Is the transaction indicative of noncompliance or insider trading?

The filing indicates the sale is under a 10b5-1 plan and includes the required representation that the seller does not possess undisclosed material information; the notice itself does not allege noncompliance.